Public, NASDAQ:OREX
NASDAQ Global Market
Orexigen(R) Therapeutics To Discuss Two Advanced-Stage Obesity Products That Target The Brain's Critical Role In Regulating Body Weight
Date: Sun, 15 Jun 2008 07:13:41 GMT
Tags:
Orexigen(R) Therapeutics To Discuss Two Advanced-Stage Obesity Products That Target The Brain's Critical Role In Regulating Body Weight
Medical News Today (press release) - Jun 15, 2008
Medical News Today (press release) - Jun 15, 2008
Orexigen ~® Therapeutics , Inc . ( Nasdaq : OREX ) , a biopharmaceutical company focused on the treatment of central nervous system ( CNS ) disorders , including obesity , is scheduled to present ...
Orexigen(R) Therapeutics to Discuss Two Advanced-Stage Obesity Products That Target the Brain's Critical Role in Regulating Body Weight
Date: Fri, 13 Jun 2008 03:43:41 GMT
Tags:
Orexigen(R) Therapeutics to Discuss Two Advanced-Stage Obesity Products That Target the Brain's Critical Role in Regulating Body Weight
RedOrbit - Jun 13, 2008
RedOrbit - Jun 13, 2008
Orexigen ( R ) Therapeutics , Inc . ( Nasdaq : OREX ) , a biopharmaceutical company focused on the treatment of central nervous system ( CNS ) disorders , including obesity , is scheduled to ...
Orexigen Therapeutics says Contrave shows potential to reduce diabetes and hear disease risk - Update
Date: Mon, 09 Jun 2008 15:43:38 GMT
Tags:
Orexigen Therapeutics says Contrave shows potential to reduce diabetes and hear disease risk - Update
RTT News - Jun 9, 2008
RTT News - Jun 9, 2008
( RTTNews ) - Saturday , Orexigen Therapeutics , Inc . ( OREX : News , Chart , Quote ) , a biopharmaceutical company , said that a review of data from its Contrave Phase IIb trial showed that ...
Orexigen(R) Therapeutics Announces That Contrave(R) May Reverse The Incidence Of Metabolic Syndrome
Date: Mon, 09 Jun 2008 10:22:26 GMT
Tags:
Orexigen(R) Therapeutics Announces That Contrave(R) May Reverse The Incidence Of Metabolic Syndrome
Medical News Today (press release) - Jun 9, 2008
Medical News Today (press release) - Jun 9, 2008
Orexigen ~® Therapeutics , Inc . ( Nasdaq : OREX ) , a biopharmaceutical company focused on the treatment of central nervous system disorders , including obesity , announced that based on a ...
Orexigen says Contrave drug may reduce risks for diabetes and heart disease - HemscottOrexigen Therapeutics says Contrave shows potential to reduce diabetes and hear disease risk - Update
Date: Sat, 07 Jun 2008 20:15:36 GMT
Tags:
Orexigen Therapeutics says Contrave shows potential to reduce diabetes and hear disease risk - Update
RTT News - Jun 7, 2008
RTT News - Jun 7, 2008
( RTTNews ) - Saturday , Orexigen Therapeutics , Inc . ( OREX : News , Chart , Quote ) , a biopharmaceutical company , said that a review of data from its Contrave Phase IIb trial showed that ...
Orexigen(R) Therapeutics to Discuss Two Advanced-Stage Obesity Products That Target the Brain's Critical Role in Regulating Body Weight (Business Wire)
Date: Thu, 12 Jun 2008 11:01:00 Etc/GMT
Tags:
Orexigen(R) Therapeutics Announces That Contrave(R) May Reverse the Incidence of Metabolic Syndrome (Business Wire)
Date: Sat, 7 Jun 2008 17:01:00 Etc/GMT
Tags:
Orexigen(R) Therapeutics to Present at Upcoming Investor Conferences (Business Wire)
Date: Wed, 4 Jun 2008 11:04:00 Etc/GMT
Tags:
Orexigen wins patent covering lead obesity drug (AP)
Date: Tue, 27 May 2008 14:08:05 Etc/GMT
Tags:
Obesity drug developer Orexigen Therapeutics Inc. said Tuesday the U.S. Patent and Trademark Office issued a patent covering its lead candidate.
Orexigen(R) Therapeutics Issued a Key U.S. Patent Covering Composition of Contrave(R) into 2025 (Business Wire)
Date: Tue, 27 May 2008 11:10:00 Etc/GMT
Tags: